34 fabulous photographs from 2021
Join us for a whirlwind photographic tour of the year 2021, from lockdowns, to Dubai weddings, cowboys and Covid shots.
Join us for a whirlwind photographic tour of the year 2021, from lockdowns, to Dubai weddings, cowboys and Covid shots.
Safety and efficacy of another booster shot is to be determined by a study of 150 healthcare workers whose antibodies from the third shot are waning.
Because Omicron is very infectious and not aggressive in causing serious illness, it may lead to natural herd immunity and the post-pandemic era.
Citizens over 60 and medical personnel will soon get a fourth dose of the Pfizer-BioNTech vaccine in the face of Omicron wave.
Study from Israel’s Sheba Medical Center suggests booster helps prevent Covid-19 caused by Omicron variant but not as well as against Delta variant.
Israeli study determines that a third dose five months after the initial two Pfizer doses reduces risk of death from the disease dramatically.
Israeli experts explain what is known about the new Covid variant, how the vaccines may fare against it, and why this isn’t the final coronavirus mutation.
In the last year, Israel has been at the forefront of vaccination rollouts for adults and teenagers, pioneered a vaccine passport and, in recent months, has spearheaded the use of booster shots.
Oramed’s Oravax Medical and Genomma Lab Internacional announce joint venture to develop and commercialize vaccine for Latin America.
Israel is among the first countries to recommend vaccinating young kids against the Covid-19 virus. A pediatrician on the advisory committee explains why.
Jewish, Muslim, Christian and Baháʼí leaders agree on religious obligation to save lives and the effectiveness and safety of the vaccine.
Coalition for Epidemic Preparedness Innovations grant will help establish proof of concept for vaccines protective against existing and new strains.
Study is first to estimate effectiveness of a third dose of an mRNA Covid-19 vaccine against severe outcomes and within subgroups.
Israeli study also shows 93% effectiveness in preventing the spread of symptomatic infection within seven to 21 days of the second Pfizer dose.
Published in New England Journal of Medicine, prospective study of nearly 5,000 vaccinated healthcare workers supports decision to give booster shots.